Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

NCT01930175 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped The study recruitment was terminated in Dec-2015 for strategic reasons related to the development of the compound.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals